Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heyan Danggui Yixue oral liquid for abnormal uterine bleeding with anemia
ChiCTR2400086279Phase 4Not yet recruiting
- Sponsor
- The First Hospital of Hebei Medical University
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Heyan Danggui Yixue in menstrual disorders and anaemia (2 arms), sponsored by The First Hospital of Hebei Medical University. Primary endpoint: Hemoglobin. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
Heyan Danggui Yixue
03
Conditions
menstrual disordersanaemia
Beyond the preview
Go deeper on ChiCTR2400086279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086279.